+499.5%
MRNA vs GLXY
+8.0%
+491.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GLXY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.6% | -1.6% | -2.0% |
| 7D | +5.5% | +13.4% | -8.0% | 0.0% |
| 30D | +158.7% | +38.1% | +120.6% | +131.7% |
| 3M | +182.1% | -7.3% | +189.4% | +173.7% |
| 6M | +151.8% | +8.2% | +143.6% | +132.0% |
| YTD | +393.6% | +17.8% | +375.8% | +332.1% |
| 1Y | +499.5% | +14.9% | +484.5% | +387.3% |
| All | +499.5% | +8.0% | +491.4% | +387.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GLXY.
Daily Out/Under-Performance
Portfolio return minus GLXY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLXY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GLXY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling